Chemed (CHE) Depreciation & Amortization (CF) (2014 - 2026)

Chemed has reported Depreciation & Amortization (CF) for 13 years, with the latest figure at $17.0 million in Q2 2026.

• Depreciation & Amortization (CF) for Q2 2026 came in at $17.0 million, up 4.46% year-over-year; the trailing twelve-month figure through Jun 2026 was $66.4 million (up 4.1% YoY), and the FY2025 annual result was $64.8 million, up 2.84% from the prior year.
• Depreciation & Amortization (CF) rose to $17.0 million in Q2 2026, from $16.9 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $17.0 million in Q2 2026 and troughed at $14.6 million in Q4 2022.
• A 5-year average of $15.7 million and a median of $15.7 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• The widest annual swing landed in 2022, when Depreciation & Amortization (CF) slipped 5.51%; it then grew 6.82% in 2024.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $14.6 million in 2022, then advanced by 6.37% to $15.5 million in 2023, then grew by 1.88% to $15.8 million in 2024, then rose by 3.15% to $16.3 million in 2025, then grew by 4.02% to $17.0 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $17.0 million in Q2 2026, $16.9 million in Q1 2026, and $16.3 million in Q4 2025.